M. Sancar Et Al. , "Cardiovascular disease risk assessment among patients with hyperlipidemia at a community pharmacy setting," INTERNATIONAL JOURNAL OF CLINICAL PHARMACY , vol.33, no.2, pp.429-430, 2011
Sancar, M. Et Al. 2011. Cardiovascular disease risk assessment among patients with hyperlipidemia at a community pharmacy setting. INTERNATIONAL JOURNAL OF CLINICAL PHARMACY , vol.33, no.2 , 429-430.
Sancar, M., Akyildiz, E., Okuyan, B., Rabus, S. A., Carli, B. S., Yilmaz, Z., ... Izzettin, F. V.(2011). Cardiovascular disease risk assessment among patients with hyperlipidemia at a community pharmacy setting. INTERNATIONAL JOURNAL OF CLINICAL PHARMACY , vol.33, no.2, 429-430.
Sancar, M. Et Al. "Cardiovascular disease risk assessment among patients with hyperlipidemia at a community pharmacy setting," INTERNATIONAL JOURNAL OF CLINICAL PHARMACY , vol.33, no.2, 429-430, 2011
Sancar, M. Et Al. "Cardiovascular disease risk assessment among patients with hyperlipidemia at a community pharmacy setting." INTERNATIONAL JOURNAL OF CLINICAL PHARMACY , vol.33, no.2, pp.429-430, 2011
Sancar, M. Et Al. (2011) . "Cardiovascular disease risk assessment among patients with hyperlipidemia at a community pharmacy setting." INTERNATIONAL JOURNAL OF CLINICAL PHARMACY , vol.33, no.2, pp.429-430.
@article{article, author={M. Sancar Et Al. }, title={Cardiovascular disease risk assessment among patients with hyperlipidemia at a community pharmacy setting}, journal={INTERNATIONAL JOURNAL OF CLINICAL PHARMACY}, year=2011, pages={429-430} }